MonkslandIrelandCounty Roscommon
chemXplore tracks 3 projects at Monksland, of which one is active.
1 expansion.
Owners and developers: Novo Nordisk (1)
Targeting: Glucagon-like peptide-1 (1)
The company expands its API services with continuous flow technology, enhancing product quality, process safety, and efficiency. A 4-year strategy focuses on advanced synthesis methods.
The new facility, supported by IDA Ireland, represents a €50 million investment and will employ up to 50 people. It has received FDA and Irish regulatory approval.
The new facility in Roscommon will cost $60-$68M, create 160 construction jobs, and 50 permanent jobs. Supported by IDA Ireland, it marks Jazz's first manufacturing site. Completion expected in 2016.
